GEN Exclusives

More »
New Products

Related to Firms Combine Technologies to Optimize ChIP Studies

    • Blood RNA Sample Prep
    • Biomatrica
    • The RNAgard® blood system is an integrated system designed for the collection, preservation, and purification of RNA from whole blood samples. The system consists of Vacuette® RNAgard blood tubes and the BioMaxi™ blood RNA purification ki
    • ChIP Assay Range
    • Porvair Sciences
    • Developed in conjunction with the department of life sciences at University of Swansea, U.K., Chromatrap® chromatin immunoprecipitation assay range uses a solid-phase porous polymer functionalized with protein A. Independent tests with Chromat
    • Chromatin Immunoprecipitation Kits
    • EMD Millipore
    • Magna ChIP® HiSens chromatin immunoprecipitation kits enable target chromatin enrichment from both low and high amounts of input chromatin while delivering low backgrounds, high signal-to-noise ratios, and ultrasensitive detection that is comp
    • Chromatin Preparation and Optimization Kit
    • EMD Millipore
    • The PureEpi™ chromatin preparation and optimization kit is designed for the preparation of samples for ChIP application. The kit’s materials, which include a set of validated reagents, may be used to enable chromatin preparation from either culture
    • Kits for Analyzing Modified Cytosines
    • Cambridge Epigenetix
    • TrueMethyl™ kits provide quantitative, accurate and repeatable single-base resolution sequencing of the modified bases hydroxymethylcytosine (5-hmC) and methylcytosine (5-mC) in genomic DNA. This capability is attributable to the kits’ utiliza
  • Page 1 of 1 (5 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?